Li Jing, Zhu Na, Wang Yaqiong, Bao Yanlei, Xu Feng, Liu Fengjuan, Zhou Xuefeng
Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, People's Republic of China.
Clinical Trial Research Center, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Central Hospital, Qingdao, People's Republic of China.
Diabetes Metab Syndr Obes. 2023 Dec 28;16:4269-4282. doi: 10.2147/DMSO.S441399. eCollection 2023.
Diabetes is a major global public health problem with high incidence and case fatality rates. Traditional Chinese medicine (TCM) is used to help manage Type 2 Diabetes Mellitus (T2DM) and has steadily gained international acceptance. Despite being generally accepted in daily practice, the TCM methods and hypotheses for understanding diseases lack applicability in the current scientific characterization systems. To date, there is no systematic evaluation system for TCM in preventing and treating T2DM. Metabonomics is a powerful tool to predict the level of metabolites in vivo, reveal the potential mechanism, and diagnose the physiological state of patients in time to guide the follow-up intervention of T2DM. Notably, metabolomics is also effective in promoting TCM modernization and advancement in personalized medicine. This review provides updated knowledge on applying metabolomics to TCM syndrome differentiation, diagnosis, biomarker discovery, and treatment of T2DM by TCM. Its application in diabetic complications is discussed. The combination of multi-omics and microbiome to fully elucidate the use of TCM to treat T2DM is further envisioned.
糖尿病是一个全球性的重大公共卫生问题,发病率和病死率都很高。中医被用于辅助管理2型糖尿病(T2DM),并逐渐获得国际认可。尽管在日常实践中已被普遍接受,但中医理解疾病的方法和假说在当前的科学表征系统中缺乏适用性。迄今为止,尚无针对中医防治T2DM的系统评价体系。代谢组学是预测体内代谢物水平、揭示潜在机制、及时诊断患者生理状态以指导T2DM后续干预的有力工具。值得注意的是,代谢组学在促进中医现代化和个性化医学发展方面也很有效。本文综述提供了关于将代谢组学应用于中医对T2DM的辨证、诊断、生物标志物发现及治疗的最新知识。还讨论了其在糖尿病并发症中的应用。进一步设想了多组学与微生物组相结合以充分阐明中医治疗T2DM的用途。